Enhanced CD4+T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy

被引:288
作者
Le, Tuan [1 ,2 ,3 ]
Wright, Edwina J. [7 ,8 ]
Smith, Davey M. [9 ,10 ]
He, Weijing [1 ,2 ,3 ]
Catano, Gabriel [1 ,2 ,3 ]
Okulicz, Jason F. [6 ]
Young, Jason A. [10 ]
Clark, Robert A. [1 ,2 ,3 ]
Richman, Douglas D. [9 ,10 ,11 ]
Little, Susan J. [10 ]
Ahuja, Sunil K. [1 ,2 ,3 ,4 ,5 ]
机构
[1] S Texas Vet Hlth Care Syst, Vet Affairs Res Ctr AIDS & HIV Infect 1, San Antonio, TX 78229 USA
[2] S Texas Vet Hlth Care Syst, Ctr Personalized Med, San Antonio, TX USA
[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA
[4] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA
[5] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA
[6] San Antonio Mil Med Ctr, Infect Dis Serv, Ft Sam Houston, TX USA
[7] Monash Univ, Alfred Hosp, Dept Infect Dis, Burnet Inst, Melbourne, Vic 3181, Australia
[8] Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia
[9] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA
[10] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
[11] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; LYMPHOID-TISSUE STRUCTURE; SOCIETY-USA PANEL; T-CELLS; PRIMARY INFECTION; AIDS; SEROCONVERSION; CD4; RECOMMENDATIONS; RECONSTITUTION;
D O I
10.1056/NEJMoa1110187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The relationship between the timing of the initiation of antiretroviral therapy (ART) after infection with human immunodeficiency virus type 1 (HIV-1) and the recovery of CD4+ T-cell counts is unknown. Methods In a prospective, observational cohort of persons with acute or early HIV-1 infection, we determined the trajectory of CD4+ counts over a 48-month period in partially overlapping study sets: study set 1 included 384 participants during the time window in which they were not receiving ART and study set 2 included 213 participants who received ART soon after study entry or sometime thereafter and had a suppressed plasma HIV viral load. We investigated the likelihood and rate of CD4+ T-cell recovery to 900 or more cells per cubic millimeter within 48 months while the participants were receiving viral-load-suppressive ART. Results Among the participants who were not receiving ART, CD4+ counts increased spontaneously, soon after HIV-1 infection, from the level at study entry (median, 495 cells per cubic millimeter; interquartile range, 383 to 622), reached a peak value (median, 763 cells per cubic millimeter; interquartile range, 573 to 987) within approximately 4 months after the estimated date of infection, and declined progressively thereafter. Recovery of CD4+ counts to 900 or more cells per cubic millimeter was seen in approximately 64% of the participants who initiated ART earlier (<= 4 months after the estimated date of HIV infection) as compared with approximately 34% of participants who initiated ART later (>4 months) (P<0.001). After adjustment for whether ART was initiated when the CD4+ count was 500 or more cells per cubic millimeter or less than 500 cells per cubic millimeter, the likelihood that the count would increase to 900 or more cells per cubic millimeter was lower by 65% (odds ratio, 0.35), and the rate of recovery was slower by 56% (rate ratio, 0.44), if ART was initiated later rather than earlier. There was no association between the plasma HIV RNA level at the time of initiation of ART and CD4+ T-cell recovery. Conclusions A transient, spontaneous restoration of CD4+ T-cell counts occurs in the 4-month time window after HIV-1 infection. Initiation of ART during this period is associated with an enhanced likelihood of recovery of CD4+ counts. (Funded by the National Institute of Allergy and Infectious Diseases and others.)
引用
收藏
页码:218 / 230
页数:13
相关论文
共 33 条
[1]   Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection [J].
Ananworanich, Jintanat ;
Schuetz, Alexandra ;
Vandergeeten, Claire ;
Sereti, Irini ;
de Souza, Mark ;
Rerknimitr, Rungsun ;
Dewar, Robin ;
Marovich, Mary ;
van Griensven, Frits ;
Sekaly, Rafick ;
Pinyakorn, Suteeraporn ;
Phanuphak, Nittaya ;
Trichavaroj, Rapee ;
Rutvisuttinunt, Wiriya ;
Chomchey, Nitiya ;
Paris, Robert ;
Peel, Sheila ;
Valcour, Victor ;
Maldarelli, Frank ;
Chomont, Nicolas ;
Michael, Nelson ;
Phanuphak, Praphan ;
Kim, Jerome H. .
PLOS ONE, 2012, 7 (03)
[2]  
[Anonymous], GUID US ANT AG HIV 1
[3]   Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy (vol 487, pg 482, 2012) [J].
Archin, N. M. ;
Liberty, A. L. ;
Kashuba, A. D. ;
Choudhary, S. K. ;
Kuruc, J. D. ;
Crooks, A. M. ;
Parker, D. C. ;
Anderson, E. M. ;
Kearney, M. F. ;
Strain, M. C. ;
Richman, D. D. ;
Hudgens, M. G. ;
Bosch, R. J. ;
Coffin, J. M. ;
Eron, J. J. ;
Hazuda, D. J. ;
Margolis, D. M. .
NATURE, 2012, 489 (7416) :460-460
[4]   Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy [J].
Archin, N. M. ;
Liberty, A. L. ;
Kashuba, A. D. ;
Choudhary, S. K. ;
Kuruc, J. D. ;
Crooks, A. M. ;
Parker, D. C. ;
Anderson, E. M. ;
Kearney, M. F. ;
Strain, M. C. ;
Richman, D. D. ;
Hudgens, M. G. ;
Bosch, R. J. ;
Coffin, J. M. ;
Eron, J. J. ;
Hazuda, D. J. ;
Margolis, D. M. .
NATURE, 2012, 487 (7408) :482-U1650
[5]   Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites [J].
Belloso, W. H. ;
Orellana, L. C. ;
Grinsztejn, B. ;
Madero, J. S. ;
La Rosa, A. ;
Veloso, V. G. ;
Sanchez, J. ;
Ismerio Moreira, R. ;
Crabtree-Ramirez, B. ;
Garcia Messina, O. ;
Lasala, M. B. ;
Peinado, J. ;
Losso, M. H. .
HIV MEDICINE, 2010, 11 (09) :554-564
[6]  
BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x
[7]   HIV infection and the gastrointestinal immune system [J].
Brenchley, J. M. ;
Douek, D. C. .
MUCOSAL IMMUNOLOGY, 2008, 1 (01) :23-30
[8]   HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects [J].
Buzon, Maria J. ;
Massanella, Marta ;
Llibre, Josep M. ;
Esteve, Anna ;
Dahl, Viktor ;
Puertas, Maria C. ;
Gatell, Josep M. ;
Domingo, Pere ;
Paredes, Roger ;
Sharkey, Mark ;
Palmer, Sarah ;
Stevenson, Mario ;
Clotet, Bonaventura ;
Blanco, Julia ;
Martinez-Picado, Javier .
NATURE MEDICINE, 2010, 16 (04) :460-U143
[9]   CHARACTERIZATION OF LYMPHOCYTE-T RESPONSES DURING PRIMARY INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS [J].
COOPER, DA ;
TINDALL, B ;
WILSON, EJ ;
IMRIE, AA ;
PENNY, R .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (05) :889-896
[10]  
Drechsler H, 2012, 19 INT AIDS C WASH D